PT1413305E - Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria - Google Patents

Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria

Info

Publication number
PT1413305E
PT1413305E PT02745440T PT02745440T PT1413305E PT 1413305 E PT1413305 E PT 1413305E PT 02745440 T PT02745440 T PT 02745440T PT 02745440 T PT02745440 T PT 02745440T PT 1413305 E PT1413305 E PT 1413305E
Authority
PT
Portugal
Prior art keywords
azolilcabrinol
heteroaril
aril
derivatives
treatment
Prior art date
Application number
PT02745440T
Other languages
English (en)
Portuguese (pt)
Inventor
Merce-Vidal Ramon
Andaluz-Mataro Blas
Frigola-Constansa Jordi
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of PT1413305E publication Critical patent/PT1413305E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT02745440T 2001-07-06 2002-07-01 Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria PT1413305E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101587A ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Publications (1)

Publication Number Publication Date
PT1413305E true PT1413305E (pt) 2006-09-29

Family

ID=8498326

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02745440T PT1413305E (pt) 2001-07-06 2002-07-01 Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria

Country Status (23)

Country Link
US (2) US20030022925A1 (el)
EP (1) EP1413305B1 (el)
JP (1) JP2004521150A (el)
KR (1) KR20040030788A (el)
CN (1) CN1543344A (el)
AR (1) AR034679A1 (el)
AT (1) ATE327752T1 (el)
BR (1) BR0211237A (el)
CA (1) CA2452646A1 (el)
CY (1) CY1105113T1 (el)
DE (1) DE60211913T2 (el)
DK (1) DK1413305T3 (el)
ES (2) ES2180449B1 (el)
MA (1) MA27056A1 (el)
MX (1) MXPA04000065A (el)
NO (1) NO20040031L (el)
NZ (1) NZ530817A (el)
PL (1) PL369062A1 (el)
PT (1) PT1413305E (el)
RU (1) RU2308268C2 (el)
UA (1) UA79238C2 (el)
WO (1) WO2003004022A1 (el)
ZA (1) ZA200400780B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070021485A1 (en) * 2005-07-22 2007-01-25 Gomis Antonio F Aryl (or heteroaryl) azolylcarbinols
ES2334548B1 (es) * 2005-07-29 2010-10-27 Laboratorios Del Dr. Esteve, S.A Forma de dosificacion de liberacion controlada de compuestos de pirazol para el tratamiento de la incontinencia urinaria.
US8722079B2 (en) 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE891865A (fr) * 1981-01-30 1982-07-22 Sandoz Sa Nouveaux medicaments a base de derives condenses de l'imidazole pour le traitement des troubles urinaires
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
JP2004521150A (ja) 2004-07-15
RU2308268C2 (ru) 2007-10-20
KR20040030788A (ko) 2004-04-09
ES2180449B1 (es) 2004-01-16
RU2004103475A (ru) 2005-06-10
NZ530817A (en) 2005-07-29
PL369062A1 (en) 2005-04-18
NO20040031L (no) 2004-03-02
ES2263792T3 (es) 2006-12-16
ATE327752T1 (de) 2006-06-15
EP1413305B1 (en) 2006-05-31
US20030022925A1 (en) 2003-01-30
CA2452646A1 (en) 2003-01-16
BR0211237A (pt) 2004-08-10
DE60211913D1 (de) 2006-07-06
ZA200400780B (en) 2005-01-31
MXPA04000065A (es) 2004-05-21
EP1413305A1 (en) 2004-04-28
DK1413305T3 (da) 2006-09-18
MA27056A1 (fr) 2004-12-20
ES2180449A1 (es) 2003-02-01
CN1543344A (zh) 2004-11-03
UA79238C2 (en) 2007-06-11
CY1105113T1 (el) 2010-03-03
DE60211913T2 (de) 2007-05-24
US20050131049A1 (en) 2005-06-16
WO2003004022A1 (es) 2003-01-16
AR034679A1 (es) 2004-03-03

Similar Documents

Publication Publication Date Title
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
PT1413305E (pt) Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria
AU2002328060A1 (en) Disposable diaper
AU2002301636A1 (en) Disposable diaper
BR0105828B1 (pt) dispositivo para locomoÇço de deficientes fÍsicos.
AU2002364300A1 (en) Polymer derivatives for the treatment of metals
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
PT1397145E (pt) Utilizacao de inibidores da cox-2 para o tratamento de esquizofrenia ou de disturbios de tiques
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
AU2002301880A1 (en) Disposable diaper
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
ITMI20010733A0 (it) Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2002301856A1 (en) Disposable diaper
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
AU2002254167A1 (en) Intraurethral device for treating or detecting various diseases or infections of the urinary system
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
PT1363614E (pt) Utilizacao de 2-amino-1-(4-hidroxi-3-metanossulfonamidofenil) etanol para o tratamento de incontinencia urinaria
NO20033368D0 (no) Nye alkyl-fenylimino-imidazolidin-derivater for behandling av urin-inkontinens
AU2002317183B2 (en) ARYL (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
SI1413305T1 (sl) Aril (ali heteroaril) azolikarbonil derivati za zdravljenje urinske inkontinence